PUBLISHER: The Business Research Company | PRODUCT CODE: 1945297
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945297
High flow needle sets serve as medical instruments employed across a range of medical interventions to deliver fluids or medications at an accelerated flow rate. These needle sets are specifically engineered to facilitate swift administration of fluids, medications, blood components, or contrast agents, rendering them ideal for scenarios necessitating rapid infusion of sizable fluid volumes.
The primary variants of high flow needle sets include 26 gauge and 24 gauge models. 26-gauge high flow needle sets, characterized by their 26-gauge diameter, are utilized for precise and controlled delivery of fluids or medications in clinical settings, ensuring accurate administration for patients requiring meticulous dosing. These sets are available in various capacities, including those with volumes less than 10ml, between 10-100ml, and exceeding 100ml, and are constructed from a range of materials such as stainless steel and polycarbonate. They find application across various end uses, including hospitals, ambulatory surgical centers, diagnostic centers, and other medical facilities.
Tariffs are impacting the high flow needle sets market by increasing costs for imported stainless steel, polycarbonate materials, and precision manufacturing equipment. These impacts are most evident in asia-pacific and north america, where medical device supply chains rely on cross-border sourcing. Higher production costs have influenced pricing for single-use and reusable needle sets used in hospitals and diagnostic centers. However, tariffs are also encouraging local manufacturing, supplier diversification, and investment in domestic production facilities, supporting long-term supply chain resilience.
The high flow needle sets market research report is one of a series of new reports from The Business Research Company that provides high flow needle sets market statistics, including high flow needle sets industry global market size, regional shares, competitors with a high flow needle sets market share, detailed high flow needle sets market segments, market trends and opportunities, and any further data you may need to thrive in the high flow needle sets industry. This high flow needle sets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The high flow needle sets market size has grown strongly in recent years. It will grow from $1.27 billion in 2025 to $1.38 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to growth in emergency and critical care procedures, increasing volume of surgical interventions, rising demand for blood transfusions, expansion of hospital infrastructure, growing use of contrast media in diagnostic imaging.
The high flow needle sets market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to rising incidence of trauma and emergency cases, growing adoption of minimally invasive procedures requiring high flow delivery, expansion of ambulatory surgical centers, increasing focus on rapid response healthcare, rising healthcare expenditure on acute care services. Major trends in the forecast period include rising demand for rapid fluid and blood administration devices, increasing use of high flow needle sets in emergency and trauma care, growing preference for single-use high flow needle sets, expansion of high flow infusion procedures in diagnostic imaging, rising focus on improved patient safety and flow efficiency.
The increasing prevalence of surgical procedures is anticipated to drive the expansion of the high-flow needle set market in the future. Surgical procedures involve medical interventions conducted by surgeons, employing both manual and instrumental techniques to diagnose, treat, or restore tissues or organs, often with the aim of enhancing a patient's health or bodily function. The escalating number of surgical procedures can be attributed to several factors, including an aging population, advancements in medical technology, the growing incidence of chronic diseases, improved healthcare accessibility, and the broader availability of minimally invasive surgical approaches. High-flow needle sets are integral components of surgical procedures, facilitating the swift delivery of fluids, medications, or blood products directly into the bloodstream, thereby ensuring efficient and effective patient management during surgery. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based nonprofit professional organization, total surgical and non-surgical procedures rose by 3.4% in 2023, reaching 34.9 million. This increase was driven by a 5.5% growth in surgical procedures. Plastic surgeons performed more than 15.8 million surgical procedures and 19.1 million non-surgical procedures, representing a 40% overall increase in procedures over the past four years. Consequently, the increasing prevalence of surgical procedures is propelling the growth of the high-flow needle set market.
Leading companies in the high flow needle sets market are focusing on the development of portable syringe infusion systems to improve patient mobility and ease of use. These systems deliver fluids or medications to patients in a controlled manner over an extended period, enhancing convenience for both patients and healthcare providers. For example, in August 2024, Innovative Health Sciences, a UK-based medical device company, announced the expansion of its commercialization team following FDA clearance for the Insignis Syringe Infusion System. This portable, non-electric syringe driver is designed for both intravenous and subcutaneous use, offering a user-friendly solution that enables patients to manage their infusion rates with ease. The Insignis system features a selectable rate flow control device, improving patient comfort by addressing common challenges in infusion therapy, such as painful injection sites.
In October 2024, BD, a US-based medical technology company, formed a partnership with Ypsomed. The collaboration aims to develop improved self-injection systems for high-viscosity biologic drugs that are more difficult to administer. Ypsomed is a Switzerland-based medical device company specializing in needle sets and infusion products designed for efficient delivery of high-dose, high-viscosity drug formulations.
Major companies operating in the high flow needle sets market are Becton Dickinson and Company, B. Braun SE, Terumo Corporation, Nipro Corporation, Teleflex Incorporated, Smiths Medical, ICU Medical Inc., Baxter International Inc., Cardinal Health Inc., Medline Industries Inc., Retractable Technologies Inc., Vygon SA, Natus Medical Incorporated, Polymedicure Limited, Hindustan Syringes and Medical Devices, Weigao Group, Fresenius Kabi, Zibo Shanchuan Medical Instrument, KB Medical Group, Argon Medical Devices
North America was the largest region in the high flow needle sets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high flow needle sets market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the high flow needle sets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The high flow needle sets market consists of sales of extension sets, needles and catherters, injection ports, tubing, filters, and adaptors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
High Flow Needle Sets Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses high flow needle sets market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for high flow needle sets ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The high flow needle sets market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.